Citation Impact
Citing Papers
Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
2013
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Current and emerging systemic therapies for cutaneous metastatic melanoma
2019
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Influence of pH on wound-healing: a new perspective for wound-therapy?
2006 Standout
Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Signals through Multiple Pathways in Endothelial Cells
2001
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
2007
Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages
2002
Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
2010
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
2014
Mapping the expanded often inappropriate use of the Framingham Risk Score in the medical literature
2014
Epithelial Malignancies in Organ Transplant Patients: Clinical Presentation and New Methods of Treatment
2002
Aids-related malignancies
2002
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
2011
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact
2010
Nanotechnology and aptamers: applications in drug delivery
2008
Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents
1998
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
2010
Angiogenesis in health and disease
2003 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Newly approved integrase inhibitors for clinical treatment of AIDS
2014
Development of TLR9 agonists for cancer therapy
2007
Antibody therapy of cancer
2012 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus
2004 Standout
Global cancer statistics
2011 Standout
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
KSHV (HHV8) Infection
2000
Expression of K13/v-FLIP Gene of Human Herpesvirus 8 and Apoptosis in Kaposi's Sarcoma Spindle Cells
1999
Immunity, Inflammation, and Cancer
2010 Standout
Human herpesvirus type 8 infections among solid organ transplant recipients
2002
Epstein–Barr virus: 40 years on
2004 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Paradoxical roles of the immune system during cancer development
2006 Standout
Varicella zoster virus infection
2015
Effect of cytokines on HIV-induced depletion of thymocytes in vivo
2000
Signaling by Human Herpesvirus 8 kaposin A through Direct Membrane Recruitment of cytohesin-1
2001
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Small fibre pathology in patients with fibromyalgia syndrome
2013
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Kaposi's Sarcoma
2000 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Inflammasomes in health and disease
2012 StandoutNature
Identification of microRNAs of the herpesvirus family
2005 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Infection of Primary Human Monocytes by Epstein-Barr Virus
2000
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice
1999
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
IL-2–induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation
2004
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kitProto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells
2002
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
1999
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
2002
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Cytokine Storm
2020 Standout
Functional Hydrogels as Wound Dressing to Enhance Wound Healing
2021 Standout
Epidemiology and pathogenesis of Kaposi's sarcoma–associated herpesvirus
2001
Next Generation of Immunotherapy for Melanoma
2008
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients
2017
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Global cancer statistics, 2012
2015 Standout
A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus
1999
Discovery of a Viral NLR Homolog that Inhibits the Inflammasome
2011 Science
Immune Therapy for Cancer
2008
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
The Kaposi's Sarcoma-Associated Herpesvirus K12 Transcript from a Primary Effusion Lymphoma Contains Complex Repeat Elements, Is Spliced, and Initiates from a Novel Promoter
2002
Increased mTOR activation in idiopathic multicentric Castleman disease
2020
Works of Stefan Eßer being referenced
Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy
2007
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy
2002
Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin
2001
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma
1997
Therapie eines Methicillin-resistenten Staphylococcus aureus (MRSA) im Rahmen der Behandlung eines chronischen Ulkus mittels Biochirurgie
2002
Evolution of raltegravir resistance during therapy
2009
“One-stop-shop” staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
2009
Self‐administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum
2000
Phase II Trial of a Toll-Like Receptor 9–Activating Oligonucleotide in Patients With Metastatic Melanoma
2006
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease
2011
HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
1998
Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
2014
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.
2005
Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
1997
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differences.
2004
Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients
1998